CORO1C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.715800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.107400E-01
Normal-vs-Stage2
9.047000E-01
Normal-vs-Stage3
4.427200E-01
Normal-vs-Stage4
8.353000E-01
Stage1-vs-Stage2
3.045800E-01
Stage1-vs-Stage3
7.639800E-01
Stage1-vs-Stage4
2.677200E-01
Stage2-vs-Stage3
2.720200E-01
Stage2-vs-Stage4
9.208000E-01
Stage3-vs-Stage4
2.148600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.424600E-01
Normal-vs-AfricanAmerican
9.575800E-01
Normal-vs-Asian
9.349600E-01
Caucasian-vs-AfricanAmerican
9.916400E-01
Caucasian-vs-Asian
9.388200E-01
AfricanAmerican-vs-Asian
9.625400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.633600E-01
Normal-vs-Female
9.903600E-01
Male-vs-Female
8.715200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.291600E-01
Normal-vs-Age(41-60Yrs)
6.815200E-01
Normal-vs-Age(61-80Yrs)
7.881400E-01
Normal-vs-Age(81-100Yrs)
8.677600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.212190E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.574800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.168800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.557650E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.686600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.824400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.640200E-01
Normal-vs-Daily Drinker
5.332600E-01
Normal-vs-Weekly Drinker
7.089000E-01
Normal-vs-Occasional Drinker
9.530600E-01
Normal-vs-Social Drinker
8.263800E-01
Non Drinker-vs-Daily Drinker
7.592200E-01
Non Drinker-vs-Weekly Drinker
7.190000E-02
Non Drinker-vs-Occasional Drinker
5.139800E-01
Non Drinker-vs-Social Drinker
2.117600E-01
Daily Drinker-vs-Weekly Drinker
7.911700E-02
Daily Drinker-vs-Occasional Drinker
4.001400E-01
Daily Drinker-vs-Social Drinker
1.456020E-01
Weekly Drinker-vs-Occasional Drinker
4.833200E-01
Weekly Drinker-vs-Social Drinker
8.126200E-01
Occasional Drinker-vs-Social Drinker
6.367600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.996000E-01
Normal-vs-Grade 2
3.819600E-01
Normal-vs-Grade 3
7.425600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.721500E-03
Grade 1-vs-Grade 3
1.105560E-02
Grade 1-vs-Grade 4
9.996000E-01
Grade 2-vs-Grade 3
9.927800E-01
Grade 2-vs-Grade 4
3.819600E-01
Grade 3-vs-Grade 4
7.425600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.613400E-01
Normal-vs-NonDiabetic
8.950400E-01
Diabetic-vs-NonDiabetic
8.220400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.693800E-01
Normal-vs-NoPancreatitis
8.748800E-01
Pancreatitis-vs-NoPancreatitis
2.582600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.527800E-01
Normal-vs-N1
9.038000E-01
N0-vs-N1
7.421600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.031200E-01
Normal-vs-TP53-NonMutant
3.246200E-01
TP53-Mutant-vs-TP53-NonMutant
3.872400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
